Trial intelligence / Profile preview

Prophylaxis of non-bleeding gastric varices

PACTR202008491799224Phase 3Completed

Sponsor
Benha University Hospital
Start
Oct 2018
Modality
Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 3, open-label trial of carvedilol and cyanoacrylate in gastric varices, esophageal varices and Cirrhosis (3 arms), sponsored by Benha University Hospital. Primary endpoint: GI bleeding. Started Oct 2018; status: completed.

02

Drugs

carvedilolcyanoacrylate
03

Conditions

gastric varicesesophageal varicesCirrhosis

Beyond the preview

Go deeper on PACTR202008491799224.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202008491799224.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call